{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_sulfasalazine",
          "name": "Sulfasalazine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_mercaptopurine",
          "name": "Mercaptopurine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tocilizumab",
          "name": "Tocilizumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_mesalamine",
          "type": "Target",
          "label": "Off-Target Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_sulfasalazine",
          "type": "Target",
          "label": "Off-Target Sulfasalazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_budesonide",
          "type": "Target",
          "label": "Off-Target Budesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_azathioprine",
          "type": "Target",
          "label": "Off-Target Azathioprine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_mercaptopurine",
          "type": "Target",
          "label": "Off-Target Mercaptopurine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tocilizumab",
          "type": "Target",
          "label": "Off-Target Tocilizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_vedolizumab",
          "type": "Target",
          "label": "Off-Target Vedolizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "Off-Target Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Off-Target Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "Off-Target Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Off-Target Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_corticosteroids",
          "type": "Target",
          "label": "Off-Target Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway for Gastrointestinal Disorders",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse Phenotype in Gastrointestinal Function",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_mesalamine",
          "target": "n_ot_mesalamine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_sulfasalazine",
          "target": "n_ot_sulfasalazine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_budesonide",
          "target": "n_ot_budesonide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_ot_azathioprine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_mercaptopurine",
          "target": "n_ot_mercaptopurine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_tocilizumab",
          "target": "n_ot_tocilizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_ot_vedolizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_ot_corticosteroids",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路/离靶作用"
        },
        {
          "source": "n_ot_mesalamine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_sulfasalazine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_budesonide",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_azathioprine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_mercaptopurine",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_tocilizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_vedolizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot_corticosteroids",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "药物与不良反应",
          "pro_nodes": [
            "H1",
            "H2",
            "H3"
          ],
          "con_nodes": [
            "n_adv"
          ],
          "note": "支持药物有效性与潜在不良反应的对立"
        }
      ]
    },
    "counterclaims": [],
    "assumptions_challenged": [
      "药物在核心通路中的作用是否对总体治疗有益",
      "长期安全性与短期效果之间的权衡"
    ],
    "falsification_tests": [
      "是否存在长期疗效与安全性的针对性研究？",
      "是否能验证副作用与药物相关性？"
    ],
    "next_focus_for_pi": [
      "确认各药物的靶向与离靶效应，评估潜在冲突",
      "提供关于长期使用效果与不良反应的证据"
    ]
  }
}